Analyst Sees Big Rally Ahead for This Small-Cap Stock

Goldman double-upgraded FRTA stock to "buy"

by Karee Venema

Published on Aug 8, 2019 at 2:48 PM

Forterra Inc (NASDAQ:FRTA) stock is up 19.1% at $6.93 -- set for its best day since November 2017 -- after Goldman Sachs double-upgraded the drainage pipe manufacturer to "buy" from "sell," and boosted its price target to $8 from $4.25. The analyst in coverage said accelerating pricing could be a positive driver in coming quarters, and called FRTA stock a "high risk/high reward option for investors."

Goldman's new rating marks the only "buy" recommendation on FRTA, with the other three covering analysts calling the stock a tepid "hold." The average 12-month price target, meanwhile, sits at a roughly 10% discount to current levels at $6.25. With the shares now up 85% year-to-date and holding above their 200-day moving average, more analyst adjustments could come down the pike.

Elsewhere on Wall Street, FRTA shorts are likely feeling the heat. There are currently 4.31 million Forterra shares controlled by these bearish bettors, representing 23.3% of the stock's available float, or 27.2 times the average daily pace of trading. A capitulation from some of the weaker bearish hands could keep the wind at the equity's back.

Today's options traders are positioning for more upside. With just over two more hours left in today's session, 176 FRTA options are on the tape. While light on an absolute basis, this is four times what's typically seen at this point. Speculators may be purchasing new positions at the August 7.50 call, meaning they expect the stock to break out above $7.50 by expiration at the close next Friday, Aug. 16.

frta stock daily price chart on aug 8


a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.
Wall Street Reacts to Fed Decision, Trade Deal
Investors waited and reacted to the Fed decision and trade headlines
Sarepta Therapeutics Stock Eyes Best Day in 3 Years on FDA Reversal
SRPT is buzzing on the FDA's change of heart
The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.